Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New insights on how FMDV replicates
The team are now looking at how mutations in polyproteins could be used for producing attenuated vaccines.
Tiny protein could be the key to better vaccines  

Fresh insights on the replication processes of foot-and-mouth disease virus (FMDV) could pave the way for more effective vaccines, scientists say.

New findings published in PLOS Pathogens describe a tiny protein called 3B3, which is known to play a major role in the replication of FMDV. However, it also helps to increase the efficiency with which it can pack information into the genome, according to the Pirbright Institute and the University of Leeds.

FMD has a small amount of genetic material, so it has found ways to multiply its functions. During replication, the virus creates a string of proteins called polyproteins which are then cut up into their individual proteins. The research team discovered that 3B3 is key to directing the processing of the P3 polyprotein into its constituent parts.

Such methods are also used by other members of the picornavirus family, such as poliovirus, as well as non-picornaviruses.

Scientists say that systems such as these could be exploited to develop attenuated vaccines. The team are now looking at how mutations in polyproteins could be used for producing such vaccines.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.